Form 4: Pfizer Director Acquires Phantom Stock Units

Pfizer Inc. director James C. Smith acquired 1,852.614 phantom stock units, representing deferred compensation, on June 26, 2026.

Summary

• James C. Smith, a Director at Pfizer Inc., acquired 1,852.614 phantom stock units on June 26, 2026.
• These units are part of a deferred director's compensation plan, including dividend equivalents.
• The phantom stock units are settled in cash or common stock upon the director's retirement from the Board.
• Following this transaction, Smith beneficially owns 182,886.00 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a routine transaction related to director compensation rather than a significant strategic or financial event.

Positives

• Director compensation plan in place, indicating a commitment to retaining experienced board members.
• Acquisition of phantom stock units by a director suggests confidence in the company's future value.

Future Outlook

The phantom stock units are settled in cash or common stock at the director's election following retirement from the Board of Directors, indicating a future potential distribution of value to the reporting person.

Industry Context

StockSavvy.ai notes that the acquisition of phantom stock units by a director is a common practice in the pharmaceutical industry to align executive and director interests with long-term shareholder value. This filing reflects standard insider reporting procedures.

Related Party Transactions

• Acquisition of phantom stock units by Director James C. Smith, representing deferred director's compensation.

Stakeholder Impact

• Shareholders: The transaction reflects a standard compensation practice for directors, with no immediate direct impact on share price or ownership structure beyond the reporting person's holdings.
• Directors: Reinforces the alignment of director compensation with company performance through deferred equity-like instruments.

Next Steps

• Settlement of phantom stock units in cash or common stock upon reporting person's retirement from the Board of Directors.

Key Dates

Keywords

Pfizer Inc., PFE, Form 4, Insider Trading, Director Compensation, Phantom Stock Units, Beneficial Ownership, Securities Exchange Act